13 marzo 2015
An FDA-approved drug for high blood pressure, guanabenz, prevents myelin loss and alleviates clinical symptoms of multiple sclerosis (MS) in animal models, according to a new study. The drug appears to enhance an innate cellular mechanism that protects myelin-producing cells.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/8XNY6m8IvsE/150313083233.htm
